Literature DB >> 27796748

Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View.

Cynthia Alexandra Martin-Jiménez1, Diana Milena Gaitán-Vaca1, Valentina Echeverria2, Janneth González3, George E Barreto4,5.   

Abstract

Obesity is considered one of the greatest risk to human health and is associated with several factors including genetic components, diet, and physical inactivity. Recently, the relationship between obesity and numerous progressive and aging-related neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD) have been observed. Thus, the involvement of the most abundant and heterogeneous group of glial cells in neurodegenerative diseases, the astrocytes, is caused by a combination of the failure on their normal homeostatic functions and the increase of toxic metabolites upon pathological event. Upon brain damage, molecular signals induce astrocyte activation and migration to the site of injury, entering in a highly active state, with the aim to contribute to ameliorating or worsening the pathology. In this regard, the aim of this review is to elucidate the relationship between obesity, Alzheimer's disease, and Parkinson's disease and highlight the role of astrocytes in these pathologies.

Entities:  

Keywords:  Alzheimer’s disease; Astrocytes; Neuroinflammation; Obesity; Parkinson’s disease

Mesh:

Year:  2016        PMID: 27796748     DOI: 10.1007/s12035-016-0193-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  16 in total

Review 1.  White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.

Authors:  Freddy J Alfaro; Anna Gavrieli; Patricia Saade-Lemus; Vasileios-Arsenios Lioutas; Jagriti Upadhyay; Vera Novak
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

Review 2.  Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors.

Authors:  S Mohammadi; M Dolatshahi; F Rahmani
Journal:  J Endocrinol Invest       Date:  2020-06-04       Impact factor: 4.256

Review 3.  Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights.

Authors:  Sarvin Sanaie; Saba Nikanfar; Zahra Yousefi Kalekhane; Akbar Azizi-Zeinalhajlou; Saeed Sadigh-Eteghad; Mostafa Araj-Khodaei; Mohammad Hossein Ayati; Sasan Andalib
Journal:  Metab Brain Dis       Date:  2022-08-20       Impact factor: 3.655

Review 4.  Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation.

Authors:  Qin Zhang; Kangyu Jin; Bing Chen; Ripeng Liu; Shangping Cheng; Yuyan Zhang; Jing Lu
Journal:  Front Neurosci       Date:  2022-07-06       Impact factor: 5.152

Review 5.  Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.

Authors:  Elena A Kosenko; Lyudmila A Tikhonova; Carmina Montoliu; George E Barreto; Gjumrakch Aliev; Yury G Kaminsky
Journal:  Front Neurosci       Date:  2018-01-05       Impact factor: 4.677

6.  High-Fat Diet-Induced Weight Gain, Behavioral Deficits, and Dopamine Changes in Young C57BL/6J Mice.

Authors:  Jian Han; Pragya Nepal; Anuoluwapo Odelade; Frederick D Freely; Destiny M Belton; Joseph L Graves; Antoniette M Maldonado-Devincci
Journal:  Front Nutr       Date:  2021-01-20

7.  Diet-Induced Obesity Disrupts Trace Element Homeostasis and Gene Expression in the Olfactory Bulb.

Authors:  Melissa S Totten; Derek M Pierce; Keith M Erikson
Journal:  Nutrients       Date:  2020-12-21       Impact factor: 5.717

Review 8.  The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer's Disease.

Authors:  Ancuta-Veronica Lupaescu; Monica Iavorschi; Mihai Covasa
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

Review 9.  Potential Crosstalk Between Parkinson's Disease and Energy Metabolism.

Authors:  Meiqiu Liu; Qian Jiao; Xixun Du; Mingxia Bi; Xi Chen; Hong Jiang
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

10.  The Protective Effects of Acer okamotoanum and Isoquercitrin on Obesity and Amyloidosis in a Mouse Model.

Authors:  Ji Hyun Kim; Sanghyun Lee; Eun Ju Cho
Journal:  Nutrients       Date:  2020-05-09       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.